(firstQuint)A Multiple-ascending-dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of MEDI0382 in Overweight and Obese Subjects With Type 2 Diabetes.

 This is a randomized, double-blind, placebo controlled study designed to evaluate the efficacy, safety, and PK of MEDI0382 administered as multiple daily SC doses to subjects with T2DM.

 Approximately one hundred and seven subjects will be enrolled across 6 cohorts.

 In cohorts 1-3 the subjects will be randomized to MEDI0382 or placebo (3:1).

 In Cohort 4, subjects will be randomized 1:1.

 In cohort 5 and 6 subjects will be randomized to MEDI0382 or placebo (3:1).

.

 A Multiple-ascending-dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of MEDI0382 in Overweight and Obese Subjects With Type 2 Diabetes@highlight

A Phase 1/2, multiple dose study with 6 cohorts of ascending doses designed to evaluate the efficacy, safety and pharmacokinetics (PK) of MEDI0382 in patients with Type 2 Diabetes Mellitus (T2DM).

